Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1755)
Corvus Pharmaceuticals, Inc. (CRVS)
MILLER RICHARD A MD — Director
Shares
1,932
Price
$12.01
Total Value
$23.20K
Shares Held After
1,195,035
% of Holdings
0.2%
Corvus Pharmaceuticals, Inc. (CRVS)
MILLER RICHARD A MD — Director
Shares
5,000
Price
$12.05
Total Value
$60.25K
Shares Held After
1,193,103
% of Holdings
0.4%
Replimune Group, Inc. (REPL)
Hill Emily Luisa — Chief Financial Officer
Shares
7,812
Price
$5.08
Total Value
$39.68K
Shares Held After
236,556
% of Holdings
3.2%
Replimune Group, Inc. (REPL)
Sarchi Christopher — Chief Commercial Officer
Shares
8,626
Price
$5.08
Total Value
$43.82K
Shares Held After
192,962
% of Holdings
4.3%
Replimune Group, Inc. (REPL)
Schwendenman Andrew — Chief Accounting Officer
Shares
7,894
Price
$5.08
Total Value
$40.10K
Shares Held After
107,057
% of Holdings
6.9%
Oscar Health, Inc. (OSCR)
Blackley Richard Scott — Chief Financial Officer
Shares
110,000
Price
$25.03
Total Value
$2.75M
Shares Held After
1,106,660
% of Holdings
9.0%
Lexeo Therapeutics, Inc. (LXEO)
Otero Jose Manuel — Chief Operating Officer
Shares
1,302
Price
$5.07
Total Value
$6.61K
Shares Held After
130,088
% of Holdings
1.0%
Replimune Group, Inc. (REPL)
Patel Sushil — Director
Shares
37,324
Price
$5.08
Total Value
$189.61K
Shares Held After
747,492
% of Holdings
4.8%
Replimune Group, Inc. (REPL)
Astley-Sparke Philip — Director
Shares
17,657
Price
$5.08
Total Value
$89.70K
Shares Held After
1,412,414
% of Holdings
1.2%
Replimune Group, Inc. (REPL)
Xynos Konstantinos — Chief Medical Officer
Shares
14,023
Price
$5.08
Total Value
$71.24K
Shares Held After
235,662
% of Holdings
5.6%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
223
Price
$41.21
Total Value
$9.19K
Shares Held After
25,000
% of Holdings
0.9%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
1,302
Price
$40.25
Total Value
$52.40K
Shares Held After
25,223
% of Holdings
4.9%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
3,475
Price
$39.53
Total Value
$137.38K
Shares Held After
26,525
% of Holdings
11.6%
Lexeo Therapeutics, Inc. (LXEO)
Townsend Richard Nolan — Director
Shares
3,342
Price
$5.06
Total Value
$16.93K
Shares Held After
336,764
% of Holdings
1.0%
SI-BONE, Inc. (SIBN)
Maheshwari Anshul — Chief Financial Officer
Shares
2,189
Price
$14.65
Total Value
$32.08K
Shares Held After
259,877
% of Holdings
0.8%
SI-BONE, Inc. (SIBN)
Maheshwari Anshul — Chief Financial Officer
Shares
2,477
Price
$14.71
Total Value
$36.44K
Shares Held After
260,671
% of Holdings
0.9%
SI-BONE, Inc. (SIBN)
PISETSKY MICHAEL A. — SVP, Ops & Adm/Chief Legal Ofr
Shares
1,854
Price
$14.64
Total Value
$27.13K
Shares Held After
280,509
% of Holdings
0.7%
SI-BONE, Inc. (SIBN)
PISETSKY MICHAEL A. — SVP, Ops & Adm/Chief Legal Ofr
Shares
1,872
Price
$14.63
Total Value
$27.39K
Shares Held After
280,968
% of Holdings
0.7%
SI-BONE, Inc. (SIBN)
FRANCIS LAURA — Director
Shares
3,203
Price
$14.73
Total Value
$47.17K
Shares Held After
503,444
% of Holdings
0.6%
SI-BONE, Inc. (SIBN)
FRANCIS LAURA — Director
Shares
3,652
Price
$14.75
Total Value
$53.87K
Shares Held After
532,615
% of Holdings
0.7%
SI-BONE, Inc. (SIBN)
FRANCIS LAURA — Director
Shares
1,973
Price
$14.57
Total Value
$28.75K
Shares Held After
536,267
% of Holdings
0.4%
SI-BONE, Inc. (SIBN)
FRANCIS LAURA — Director
Shares
2,236
Price
$14.67
Total Value
$32.81K
Shares Held After
538,240
% of Holdings
0.4%
SI-BONE, Inc. (SIBN)
FRANCIS LAURA — Director
Shares
3,893
Price
$14.75
Total Value
$57.40K
Shares Held After
540,476
% of Holdings
0.7%
GYRE THERAPEUTICS, INC. (GYRE)
Ye Weiguo — Chief Operating Officer
Shares
200
Price
$6.62
Total Value
$1.32K
Shares Held After
700,000
% of Holdings
0.0%
Kura Oncology, Inc. (KURA)
Bair Teresa Brophy — Chief Legal Officer
Shares
2,256
Price
$9.38
Total Value
$21.16K
Shares Held After
226,931
% of Holdings
1.0%
COLLEGIUM PHARMACEUTICAL, INC (COLL)
Freund John Gordon — Director
Shares
20
Price
$34.05
Total Value
$681.00
Shares Held After
83,952
% of Holdings
0.0%
CNS Pharmaceuticals, Inc. (CNSP)
Charles Faith L. — Director
Shares
7,100
Price
$4.79
Total Value
$34.00K
Shares Held After
7,100
% of Holdings
100.0%
Orchestra BioMed Holdings, Inc. (OBIO)
Aryeh Jason — Director
Shares
665
Price
$3.75
Total Value
$2.49K
Shares Held After
118,118
% of Holdings
0.6%
Azenta, Inc. (AZTA)
Cornog William L — Director
Shares
10,000
Price
$16.38
Total Value
$163.80K
Shares Held After
19,703
% of Holdings
50.8%
BIOCRYST PHARMACEUTICALS INC (BCRX)
McKee Amy E — Director
Shares
11,180
Price
$8.97
Total Value
$100.28K
Shares Held After
31,252
% of Holdings
26.3%
Claritev Corp (CTEV)
Kim Michael — EVP, Chief Digital Officer
Shares
3,000
Price
$16.65
Total Value
$49.95K
Shares Held After
185,878
% of Holdings
1.6%
Claritev Corp (CTEV)
Dalton Travis — Director
Shares
11,200
Price
$11.88
Total Value
$133.06K
Shares Held After
45,872
% of Holdings
24.4%
Claritev Corp (CTEV)
Dalton Travis — Director
Shares
9,720
Price
$12.92
Total Value
$125.58K
Shares Held After
34,672
% of Holdings
28.0%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
50,000
Price
$19.00
Total Value
$949.76K
Shares Held After
1,122,626
% of Holdings
4.3%
Hims & Hers Health, Inc. (HIMS)
Okupe Oluyemi — Chief Financial Officer
Shares
7,950
Price
$23.64
Total Value
$187.92K
Shares Held After
262,954
% of Holdings
2.9%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
417
Price
$27.55
Total Value
$11.49K
Shares Held After
63,443
% of Holdings
0.7%
Tenaya Therapeutics, Inc. (TNYA)
Higa Tomohiro — SVP, Finance
Shares
1,485
Price
$0.79
Total Value
$1.18K
Shares Held After
118,267
% of Holdings
1.2%
Tenaya Therapeutics, Inc. (TNYA)
Tingley Whittemore — Chief Medical Officer
Shares
3,121
Price
$0.79
Total Value
$2.48K
Shares Held After
215,497
% of Holdings
1.4%
EXELIXIS, INC. (EXEL)
Senner Christopher J. — EVP and CFO
Shares
34,901
Price
$50.00
Total Value
$1.75M
Shares Held After
952,317
% of Holdings
3.5%
EXELIXIS, INC. (EXEL)
Hefti Brenda — SVP and General Counsel
Shares
6,625
Price
$50.21
Total Value
$332.64K
Shares Held After
106,762
% of Holdings
5.8%
Tenaya Therapeutics, Inc. (TNYA)
Ali Faraz — Director
Shares
3,390
Price
$0.79
Total Value
$2.69K
Shares Held After
440,014
% of Holdings
0.8%
Guardant Health, Inc. (GH)
Tariq Musa — Director
Shares
116
Price
$95.96
Total Value
$11.13K
Shares Held After
8,662
% of Holdings
1.3%
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
Edwards Carladenise Armbrister — Director
Shares
67,160
Price
$3.42
Total Value
$229.69K
Shares Held After
285,432
% of Holdings
19.0%
OMNICELL, INC. (OMCL)
Manley Corey J — EVP&CHIEF LEGAL/ADMIN OFFICER
Shares
5,025
Price
$43.22
Total Value
$217.18K
Shares Held After
112,783
% of Holdings
4.3%
OMNICELL, INC. (OMCL)
Njoku Nnamdi — EVP, Chief Operating Officer
Shares
3,090
Price
$43.22
Total Value
$133.55K
Shares Held After
154,785
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
40
Price
$570.18
Total Value
$22.81K
Shares Held After
18,876
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,322
Price
$569.56
Total Value
$752.96K
Shares Held After
18,916
% of Holdings
6.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,304
Price
$568.43
Total Value
$741.23K
Shares Held After
20,238
% of Holdings
6.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,785
Price
$568.48
Total Value
$1.58M
Shares Held After
21,542
% of Holdings
11.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,796
Price
$566.39
Total Value
$1.02M
Shares Held After
24,327
% of Holdings
6.9%
Showing 351–400 of 1755 transactions (page 8 of 36)